Good Patient-Provider Communication Associated with Less Lung Cancer Stigma

Good patient-provider communication is associated with lower levels of lung cancer stigma.
Good patient-provider communication is associated with lower levels of lung cancer stigma.

Good patient-provider communication is associated with lower levels of lung cancer stigma, a new study published online ahead of print in the journal Supportive Care in Cancer has shown.1

Because the vast majority of patients with lung cancer report stigma associated with their disease, and nearly half of patients report feeling stigmatized by their health care providers, researchers sought to evaluate whether good patient-provider communication would reduce lung cancer stigma.

“Typically associated with the causal link to smoking and the historically poor prognosis, lung cancer stigma can be seen as a risk factor for poor psychosocial and medical outcomes in the context of lung cancer diagnosis and treatment,” the authors write.

For the study, researchers enrolled 231 patients with lung cancer with varying stages of disease to complete a survey that assessed demographic and clinical characteristics, as well as patient-provider communication, and feelings of lung cancer stigma.

Results showed that good patient-provider communication was associated with lower levels of lung cancer stigma (P<.05), which remained significant after controlling for confounding demographic and clinical characteristics.

The findings suggest “that improving patient-provider communication may be a good intervention target for reducing lung cancer stigma,” the authors conclude.

REFERENCE

1. Johnson Shen M, Hamann HA, Thomas AJ, Ostroff JS. Association between patient-provider communication and lung cancer stigma [published online ahead of print November 9, 2015]. Support Care Cancer. doi:10.1007/s00520-0150-3014-0.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs